Intravitreal Ranibizumab for Acute Central Serous Chorioretinopathy

Publisher： Karger

E-ISSN： 1423-0267|229|3|152-157

ISSN： 0030-3755

Source： Ophthalmologica, Vol.229, Iss.3, 2012-12, pp. : 152-157

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravitreal Bevacizumab to Treat Acute Central Serous Chorioretinopathy: Short-Term Effect

By  

Ophthalmologica, Vol. 223, Iss. 5, 2009-06 ,pp. : 343-347

Karger

Access to resources Recommend Favorite

Intravitreal Bevacizumab for Photodynamic Therapy-Induced Massive Macular Detachment in Acute Central Serous Chorioretinopathy

By  

Case Reports in Ophthalmology, Vol. 3, Iss. 2, 2012-06 ,pp. : 196-199

Karger

Access to resources Recommend Favorite

Central Serous Chorioretinopathy

By  

Ophthalmologica, Vol. 232, Iss. 2, 2014-04 ,pp. : 65-76

Karger

Access to resources Recommend Favorite

Selective Retina Therapy in Acute and Chronic-Recurrent Central Serous Chorioretinopathy

By  

Ophthalmologica, Vol. 234, Iss. 4, 2015-0 ,pp. : 177-188

Karger

Access to resources Recommend Favorite

Central Serous Chorioretinopathy with Subretinal Deposition of Fibrin-Like Material and Its Prompt Response to Ranibizumab Injections

By  

Case Reports in Ophthalmology, Vol. 2, Iss. 1, 2011-02 ,pp. : 59-64

Karger

Access to resources Recommend Favorite